New data suggests the risk of blood clots from Astra-Zeneca is 1 in 60,000.
Ontario is going to pause first doses of the Oxford Astra-Zeneca vaccine over concerns around blood clots.
Chief Medical Officer of Health Dr. David Williams made the announcement during a press briefing this afternoon. New data suggests the risk of blood clots from Astra-Zeneca is higher then previously thought at 1 in 60,000.
This is not expected to impact the vaccine rollout in Ontario thanks to increased supply from Pfizer and Moderna.
The Province is currently reviewing data for second doses and it is possible those who got the first shot of Astra-Zeneca could end up with a second dose from Pfizer or Moderna. According to recent data, the risk of blood clots from the second dose of Astra-Zeneca is much smaller.
Dr. Williams did say anyone who already received the first dose of Astra-Zeneca did the right thing and this decision was made out of an abundance of caution. He notes the increased supply of Moderna and Pfizer helped make this an easier decision.

Alexandra Hospital Receives $100,000 from ICF
Witnesses Wanted in Crash Investigation
Christmas Parade Hits Ingersoll Tomorrow
Woodstock Man Charged in Brant County
New Offices Coming to TVDSB
UPDATE: Highway Crash Kills CMV Driver
Stairway to Oxford Hits Norwich
Oxford County Launches Tourism Surveys
Santa Claus Coming to Woodstock!
Oxford OPP Briefs - Nov. 12th, 2025
Charges Laid in Multi-Million Dollar Drug Bust
PJHL Preview - Nov. 12th to Nov. 16th
OLWN Increases Living Wage for 2025
News Poll: Santa Claus is Coming to Oxford!
Santa Claus Parade Approaches in Tillsonburg
DASO Christmas Giving of Hope Returns
Remembrance Day Ceremony Well Attended in Woodstock
Oxford OPP Briefs - November 11th, 2025
Snow Squalls Cancel Some Buses in Oxford
Budget Season Begins for Oxford County
Comments
Add a comment